E2F1 and benign prostatic hyperplasia: In the BPH group, the phosphorylation of RB and expression of E2F1 protein was significantly increased as compared to those in the Sham group, whereas administration of Fina and COFE significantly suppressed the protein expressions (Figure 5A).